Werner syndrome helicase has a critical role in DNA damage responses in the absence of a functional Fanconi anemia pathway

Cancer Research

Volumn 73, Issue 17, 2013, Pages 5497-5507

  Aggarwal, Monika ^a,d   Banerjee, Taraswi ^a   Sommers, Joshua A ^a   Iannascoli, Chiara ^c   Pichierri, Pietro ^c   Shoemaker, Robert H ^b   Brosh Jr , Robert M ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^d GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HELICASE; MITOMYCIN; PROTEIN KINASE; RAD51 PROTEIN;

ARTICLE; ATAXIA TELANGIECTASIA; CHROMOSOME ABERRATION; CONTROLLED STUDY; DNA CROSS LINKING; DNA DAMAGE; DNA END JOINING REPAIR; DOUBLE STRANDED DNA BREAK; ENZYME INHIBITION; FANCONI ANEMIA; HUMAN; HUMAN CELL; PRIORITY JOURNAL; WERNER SYNDROME;

ALKYLATING AGENTS; APOPTOSIS; ATAXIA TELANGIECTASIA MUTATED PROTEINS; BLOTTING, WESTERN; CELL PROLIFERATION; CHROMATIN; CHROMOSOMAL INSTABILITY; DNA BREAKS, DOUBLE-STRANDED; DNA REPAIR; DNA REPLICATION; DNA-ACTIVATED PROTEIN KINASE; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; ENZYME INHIBITORS; EXODEOXYRIBONUCLEASES; FANCONI ANEMIA; HCT116 CELLS; HELA CELLS; HUMANS; MALEIMIDES; MITOMYCIN; NUCLEAR PROTEINS; RAD51 RECOMBINASE; RECQ HELICASES; RNA, SMALL INTERFERING;

EID: 84883475760     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-12-2975     Document Type: Article

References (36)

1. Martin GM. Genetic syndromes in man with potential relevance to the pathobiology of aging. Birth Defects Orig Artic Ser 1978;14:5-39. (Pubitemid 8277253)
2. Yu CE, Oshima J, Fu YH, Wijsman EM, Hisama F, Alisch R, et al. Positional cloning of the Werner's syndrome gene. Science 1996;272:258-62. (Pubitemid 26119137)
3. Monnat RJ Jr. Human RECQ helicases: roles in DNA metabolism, mutagenesis and cancer biology. Semin Cancer Biol 2010;20:329-39.
4. Rossi ML, Ghosh AK, Bohr VA. Roles of Werner syndrome protein in protection of genome integrity. DNA Repair 2010;9:331-44.
5. Sharma S, Doherty KM, Brosh RM Jr. Mechanisms of RecQ helicases in pathways of DNA metabolism and maintenance of genomic stability. Biochem J 2006;398:319-37. (Pubitemid 44453376)
6. Saintigny Y, Makienko K, Swanson C, Emond MJ, Monnat RJ Jr. Homologous recombination resolution defect in Werner syndrome. Mol Cell Biol 2002;22:6971-8.
7. Sidorova JM, Li N, Folch A, Monnat RJ Jr. The RecQ helicase WRN is required for normal replication fork progression after DNA damage or replication fork arrest. Cell Cycle 2008;7:796-807. (Pubitemid 351520044)
8. Poot M, Yom JS, Whang SH, Kato JT, Gollahon KA, Rabinovitch PS. Werner syndrome cells are sensitive to DNA cross-linking drugs. FASEB J 2001;15:1224-6.
9. Poot M, Gollahon KA, Emond MJ, Silber JR, Rabinovitch PS. Werner syndrome diploid fibroblasts are sensitive to 4-nitroquinoline-N-oxide and 8-methoxypsoralen: implications for the disease phenotype. FASEB J 2002;16:757-8.
10. Cheng WH, Kusumoto R, Opresko PL, Sui X, Huang S, Nicolette ML, et al. Collaboration of Werner syndrome protein and BRCA1 in cellular responses to DNA interstrand cross-links. Nucleic Acids Res 2006;34:2751-60. (Pubitemid 43985636)
11. Cheng WH, Muftic D, Muftuoglu M, Dawut L, Morris C, Helleday T, et al. WRN is required for ATM activation and the S-phase checkpoint in response to interstrand crosslink-induced DNA double strand breaks. Mol Biol Cell 2008;19:3923-33.
12. Zhang N, Kaur R, Lu X, Shen X, Li L, Legerski RJ. The Pso4 mRNA splicing and DNA repair complex interacts with WRN for processing of DNA interstrand cross-links. J Biol Chem 2005;280:40559-67. (Pubitemid 41780545)
13. D'Andrea AD, Grompe M. The Fanconi anaemia/BRCA pathway. Nat Rev Cancer 2003;3:23-34. (Pubitemid 37328884)
14. Auerbach AD. Fanconi anemia and its diagnosis. Mutat Res 2009;668:4-10.
15. Kee Y, D'Andrea AD. Expanded roles of the Fanconi anemia pathway in preserving genomic stability. Genes Dev 2010;24:1680-94.
16. Adamo A, Collis SJ, Adelman CA, Silva N, Horejsi Z, Ward JD, et al. Preventing nonhomologous end joining suppresses DNA repair defects of Fanconi anemia. Mol Cell 2010;39:25-35.
17. Pace P, Mosedale G, Hodskinson MR, Rosado IV, Sivasubramaniam M, Patel KJ. Ku70 corrupts DNA repair in the absence of the Fanconi anemia pathway. Science 2010;329:219-23.
18. Bunting SF, Callen E, Kozak ML, Kim JM, Wong N, Lopez-Contreras AJ, et al. BRCA1 functions independently of homologous recombination in DNA interstrand crosslink repair. Mol Cell 2012;46:125-35.
19. Aggarwal M, Sommers JA, Shoemaker RH, Brosh RM Jr. Inhibition of helicase activity by a small molecule impairs Werner syndrome helicase (WRN) function in the cellular response to DNA damage or replication stress. Proc Natl Acad Sci U S A 2011;108:1525-30.
20. Bunz F, Dutriaux A, Lengauer C, Waldman T, Zhou S, Brown JP, et al. Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 1998;282:1497-501. (Pubitemid 28538613)
21. Davies SL, North PS, Dart A, Lakin ND, Hickson ID. Phosphorylation of the Bloom's syndrome helicase and its role in recovery from S-phase arrest. Mol Cell Biol 2004;24:1279-91. (Pubitemid 38112189)
22. Gaymes TJ, North PS, Brady N, Hickson ID, Mufti GJ, Rassool FV. Increased error-prone non homologous DNA end-joining -a proposed mechanism of chromosomal instability in Bloom's syndrome. Oncogene 2002;21:2525-33. (Pubitemid 34438105)
23. Schlacher K, Wu H, Jasin M. A distinct replication fork protection pathway connects fanconi anemia tumor suppressors to RAD51-BRCA1/2. Cancer Cell 2012;22:106-16.
24. Gray MD, Shen JC, Kamath-Loeb AS, Blank A, Sopher BL, Martin GM, et al. The Werner syndrome protein is a DNA helicase. Nat Genet 1997;17:100-3. (Pubitemid 27377541)
25. Kastan MB, Bartek J. Cell-cycle checkpoints and cancer. Nature 2004;432:316-23. (Pubitemid 39551659)
26. Bunting SF, Nussenzweig A. Dangerous liaisons: Fanconi anemia and toxic nonhomologous end joining in DNA crosslink repair. Mol Cell 2010;39:164-6.
27. Deans AJ, West SC. DNA interstrand crosslink repair and cancer. Nat Rev Cancer 2011;11:467-80.
28. Chen BP, Chan DW, Kobayashi J, Burma S, Asaithamby A, Morotomi-Yano K, et al. Cell cycle dependence of DNA-dependent protein kinase phosphorylation in response to DNA double strand breaks. J Biol Chem 2005;280:14709-15. (Pubitemid 40562818)
29. Ohashi A, Zdzienicka MZ, Chen J, Couch FJ. Fanconi anemia complementation group D2 (FANCD2) functions independently of BRCA2 and RAD51-associated homologous recombination in response to DNA damage. J Biol Chem 2005;280:14877-83. (Pubitemid 40562837)
30. Chen L, Huang S, Lee L, Davalos A, Schiestl RH, Campisi J, et al. WRN, the protein deficient in Werner syndrome, plays a critical structural role in optimizing DNA repair. Aging Cell 2003;2:191-9.
31. Sallmyr A, Tomkinson AE, Rassool FV. Up-regulation of WRN and DNA ligase IIIalpha in chronic myeloid leukemia: consequences for the repair of DNA double-strand breaks. Blood 2008;112:1413-23.
32. Aggarwal M, Brosh RM Jr. Hitting the bull's eye: novel directed cancer therapy through helicase-targeted synthetic lethality. J Cell Biochem 2009;106:758-63.
33. Kennedy RD, Chen CC, Stuckert P, Archila EM, de la Vega MA, Moreau LA, et al. Fanconi anemia pathway-deficient tumor cells are hypersensitive to inhibition of ataxia telangiectasia mutated. J Clin Invest 2007;117:1440-9. (Pubitemid 46718432)
34. Taniguchi T, D'Andrea AD. Molecular pathogenesis of Fanconi anemia: recent progress. Blood 2006;107:4223-33. (Pubitemid 43801344)
35. Hucl T, Gallmeier E. DNA repair: exploiting the Fanconi anemia pathway as a potential therapeutic target. Physiol Res 2011;60:453-65.
36. Chen CC, Kennedy RD, Sidi S, Look AT, D'Andrea A. CHK1 inhibition as a strategy for targeting Fanconi Anemia (FA) DNA repair pathway deficient tumors. Mol Cancer 2009;8:24.